GlaxoSmithKline

In the pipelines: Sanofi, Valneva, GSK

2023-12-01 08:00:00 Dupixent effective against BCPO Sanofi released new data on its blockbuster drug Dupicent (dupilumab), evaluated in a second phase III trial against chronic obstructive pulmonary disease (COPD). These results confirm those of the first study, with a 34% reduction in disease exacerbations. As a result, filing a Supplemental Biologics License Application (sBLA) with … Read more

The three major U.S. stock indexes collectively closed lower, with technology stocks among the top losers_Zhangchao_Cruise_ASML

2022-04-06 04:04 source:Financial Associated Press Original title: The three major U.S. stock indexes collectively closed down, with technology stocks among the top losers The three major U.S. stock indexes collectively closed lower, with technology stocks among the top losers [The three major U.S. stock indexes collectively closed down with the highest declines in technology stocks]Cailian … Read more